KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Charles River Laboratories International (CRL) Asset Writedowns and Impairment: 2015-2024

Historic Asset Writedowns and Impairment for Charles River Laboratories International (CRL) over the last 7 years, with Dec 2024 value amounting to $51.8 million.

  • Charles River Laboratories International's Asset Writedowns and Impairment rose 61.28% to $5.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $63.2 million, marking a year-over-year increase of 91.19%. This contributed to the annual value of $51.8 million for FY2024, which is 23.65% up from last year.
  • According to the latest figures from FY2024, Charles River Laboratories International's Asset Writedowns and Impairment is $51.8 million, which was up 23.65% from $41.9 million recorded in FY2023.
  • Charles River Laboratories International's Asset Writedowns and Impairment's 5-year high stood at $51.8 million during FY2024, with a 5-year trough of $1.7 million in FY2021.
  • Over the past 3 years, Charles River Laboratories International's median Asset Writedowns and Impairment value was $41.9 million (recorded in 2023), while the average stood at $33.5 million.
  • Data for Charles River Laboratories International's Asset Writedowns and Impairment shows a peak YoY soared of 524.98% (in 2023) over the last 5 years.
  • Charles River Laboratories International's Asset Writedowns and Impairment (Yearly) stood at $1.7 million in 2021, then soared by 294.47% to $6.7 million in 2022, then skyrocketed by 524.98% to $41.9 million in 2023, then increased by 23.65% to $51.8 million in 2024.